GlobeNewswire

Percona Unveils Full Conference Session Schedule for the Annual Percona Live Open Source Database Conference 2018

Dela

Sponsorship Opportunities Still Available, Advance Registration Discounts End March 4, 2018

RALEIGH, N.C., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Percona, the company that delivers enterprise-class MySQL®, MariaDB and MongoDB® and other open source database solutions and services, today announced the conference session schedule for the seventh annual Percona Live Open Source Database Conference 2018, taking place April 23-25, 2018 at the Santa Clara Convention Center in Santa Clara, Calif. Sponsorship opportunities for the conference are still available. Advance Registration Discounts can be purchased through March 4, 2018, 11:30 p.m. PST.

Percona Live Open Source Database Conference 2018 is the premier open source database event. With a theme of "Championing Open Source Databases," the conference will feature multiple tracks, including MySQL, MongoDB, Cloud, PostgreSQL, Containers and Automation, Monitoring and Ops, and Database Security. Once again, Percona will be offering a low-cost database 101 track for beginning users who want to start learning how to use and operate open source databases.

Major areas of focus at the conference will include:

  • Database operations and automation at scale, featuring speakers from Facebook, Slack, Github and more
  • Databases in the cloud - how database-as-a-service (DBAAS) is changing the DB landscape, featuring speakers from AWS, Microsoft, Alibaba and more
  • Security and compliance - how GDPR and other government regulations are changing the way we manage databases, featuring speakers from Fastly, Facebook, Pythian, Percona and more
  • Bridging the gap between developers and DBAs - finding common ground, featuring speakers from Square, Oracle, Percona and more

Conference Session Schedule
Conference sessions take place April 24-25 and will feature 90+ in-depth talks by industry experts related to each of the key areas. Several sessions from Oracle and Percona will focus on how the new features and enhancements in the upcoming release of MySQL 8.0 will impact businesses. Conference session examples include:

  • What Are the Main New Key Features in MySQL 8.0? - Geir Høydalsvik, Oracle
  • Securing Access to Facebook's Databases - Andrew Regner, Facebook
  • Designing and Launching the Next-Generation Database System @ Slack: Whiteboard to Production - Guido Iaquinti, Slack
  • MongoDB for a High Volume Logistics Application - Eric Potvin, Shipwire
  • MongoDB Cluster Topology, Management and Optimization - Steven Wang, Tesla
  • MySQL at Scale at Square - Daniel Nichter, Square
  • How Microsoft Built MySQL, PostgreSQL and MariaDB for the Cloud - Jun Su, Microsoft
  • Tuning PostgreSQL for High Write Workloads - Grant McAlister, Amazon Web Services
  • Containerizing Databases at New Relic: What We Learned - Joshua Galbraith and Bryant Vinisky, New Relic
  • GDPR & Security Compliance for the DBA - Tyler Duzan and Jeff Sandstrom, Percona
  • MySQL at Twitter: No More Forkin' - Migrating to MySQL Community version - Ronald Ramon Francisco and Jojo Antonio, Twitter
  • Database Security as a Function: Scaling to Your Organization's Needs - Laine Campbell, Fastly
  • Securing Your Data on PostgreSQL - Payal Singh, OmniTI Computer Consulting Inc.
  • MySQL Performance Optimization and Troubleshooting with Percona Monitoring and Management - Peter Zaitsev, Percona

Sponsorships
Sponsorship opportunities for Percona Live Open Source Database Conference 2018 are available and offer the opportunity to interact with the DBAs, sysadmins, developers, CTOs, CEOs, business managers, technology evangelists, solution vendors and entrepreneurs who typically attend the event. Contact live@percona.com for sponsorship details.

  • Diamond Sponsors - Continuent, VividCortex
  • Platinum - Microsoft
  • Gold Sponsors - Facebook, Grafana
  • Bronze Sponsors - Altinity, BlazingDB, SolarWinds, Timescale, TwinDB, Yelp
  • Other Sponsors - cPanel
  • Media Sponsors - Database Trends & Applications, Datanami, EnterpriseTech, HPCWire, ODBMS.org, Packt

Percona Live Conference Details

What: 
Where:     
When: 
Percona Live Open Source Database Conference 2018 
Santa Clara, Calif.
April 23-25, 2018

Company Information

Press Contact
Brigit Valencia
For Percona
(360) 597-4516
bdbvalencia@gmail.com

About Percona

With more than 3,000 customers worldwide, Percona is the only company that delivers enterprise-class solutions for both MySQL®, MongoDB® and other open source databases across traditional and cloud-based platforms. The company provides SoftwareSupport,  Consulting, and Managed Services to large, well-known global brands such as Cisco Systems, Time Warner Cable, Alcatel-Lucent, Rent the Runway and the BBC, as well as smaller enterprises looking to maximize application performance while streamlining database efficiencies. Well established as thought leaders, Percona experts author content for the Percona Database Performance Blog and the Percona Live Open Source Database Conferences draw attendees and expert technical speakers from around the world. For more information, visit www.percona.com.

Percona®, XtraBackup®, TokuDB® and Fractal Tree® are registered trademarks of Percona LLC or its subsidiaries. All other registered and unregistered trademarks in this document are the sole property of their respective owners.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Percona via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Arcoma presenterar på Redeye Life Science Day den 21:a november16.11.2018 12:53Pressmeddelande

16 November Den 21 november presenterar Jesper Söderqvist, VD på Arcoma, den senaste utvecklingen i Arcoma på Haymarket by Scandic i Stockholm. Presentationen "Arcoma, ett tillväxtbolag i en växande marknad" hålls klockan 13:00 och kan följas i livesändning på redeye.se/live/lsday-2018. Presentationen kommer även i efterhand att finnas tillgänglig på www.redeye.se/live/ls-day-2018 samt på Bolagets sida i Redeye Universe (redeye.se/company/Arcoma) Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalitet och avancerad teknik. Arcomas produkter erbjuder den senaste digitala bildtekniken kombinerat med tekniskt avancerade rörliga positioneringssystem, vilket tillsammans med ergonomisk skandinavisk design, erbjuder kunden kompletta, konfigurerbara och funktionella digitala röntgensystem. Bolagets produkter säljs via återförsäljare samt via OEM-kunder och det finns idag över 3 500 av Arcomas röntgensystem installerade

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum